Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Stem Cell Research

  Free Subscription


Articles published in Bone Marrow Transplant

Retrieve available abstracts of 247 articles:
HTML format
Text format



Single Articles


    November 2017
  1. LEHRER J, Brissot E, Ruggeri A, Dulery R, et al
    Medication adherence among allogeneic hematopoietic stem cell transplant recipients: a pilot single-center study.
    Bone Marrow Transplant. 2017 Nov 20. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  2. FAROWSKI F, Bucker V, Vehreschild JJ, Biehl L, et al
    Impact of choice, timing, sequence and combination of broad-spectrum antibiotics on the outcome of allogeneic haematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Nov 13. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  3. CROCCHIOLO R, Ringden O, Bay JO, Blaise D, et al
    Impact of HLA-G polymorphism on the outcome of allogeneic hematopoietic stem cell transplantation for metastatic renal cell carcinoma.
    Bone Marrow Transplant. 2017 Nov 13. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  4. CHAKRABORTY R, Muchtar E, Kumar SK, Buadi FK, et al
    Elevated pre-transplant C-reactive protein identifies a high-risk subgroup in multiple myeloma patients undergoing delayed autologous stem cell transplantation.
    Bone Marrow Transplant. 2017 Nov 13. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  5. DOWLING MR, Li S, Dey BR, McAfee SL, et al
    Neurologic complications after allogeneic hematopoietic stem cell transplantation: risk factors and impact.
    Bone Marrow Transplant. 2017 Nov 13. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


    October 2017
  6. ALBERT E, Solano C, Gimenez E, Focosi D, et al
    The kinetics of torque teno virus plasma DNA load shortly after engraftment predicts the risk of high-level CMV DNAemia in allogeneic hematopoietic stem cell transplant recipients.
    Bone Marrow Transplant. 2017 Oct 30. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  7. SIVARAJ D, Bacon W, Long GD, Rizzieri DA, et al
    High-dose BCNU/Melphalan conditioning regimen before autologous stem cell transplantation in newly diagnosed multiple myeloma.
    Bone Marrow Transplant. 2017 Oct 30. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  8. SHIN DY, Lee JH, Park S, Lee JO, et al
    Role of thymoglobulin in matched sibling allogeneic hematopoietic stem cell transplantation with busulfan and fludarabine conditioning in myeloid malignanicies.
    Bone Marrow Transplant. 2017 Oct 30. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  9. JEKER B, Novak U, Mansouri Taleghani B, Baerlocher GM, et al
    NSAID treatment with meloxicam enhances peripheral stem cell mobilization in myeloma.
    Bone Marrow Transplant. 2017 Oct 23. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  10. O'DWYER DN, Duvall AS, Xia M, Hoffman TC, et al
    Transbronchial biopsy in the management of pulmonary complications of hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Oct 23. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  11. SHANIS D, Anandi P, Grant C, Bachi A, et al
    Risks factors and timing of genital human papillomavirus (HPV) infection in female stem cell transplant survivors: a longitudinal study.
    Bone Marrow Transplant. 2017 Oct 16. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  12. MICHNIACKI TF, Mulcahy Levy JM, Quinones RR, Giller RH, et al
    Successful correction of familial hemophagocytic lymphohistiocytosis using prenatal genetic testing and preemptive hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Oct 16. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  13. JOFFE E, Rosenberg D, Rozovski U, Perry C, et al
    Replacing carmustine by thiotepa and cyclophosphamide for autologous stem cell transplantation in Hodgkin's and non-Hodgkin's B-cell lymphoma.
    Bone Marrow Transplant. 2017 Oct 16. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  14. KANSAGRA A, Inwards DJ, Ansell SM, Micallef IN, et al
    Infusion of autograft natural killer cell/CD14+HLA-DRDIM cell ratio predicts survival in lymphoma post autologous stem cell transplantation.
    Bone Marrow Transplant. 2017 Oct 16. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  15. GOLDSMITH SR, Slade M, DiPersio JF, Westervelt P, et al
    Donor-lymphocyte infusion following haploidentical hematopoietic cell transplantation with peripheral blood stem cell grafts and PTCy.
    Bone Marrow Transplant. 2017 Oct 16. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  16. FOUZIA NA, Edison ES, Lakshmi KM, Korula A, et al
    Long-term outcome of mixed chimerism after stem cell transplantation for thalassemia major conditioned with busulfan and cyclophosphamide.
    Bone Marrow Transplant. 2017 Oct 16. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  17. HEMMATI PG, Pfeifer K, Vuong LG, Jehn CF, et al
    Allogeneic stem cell transplantation for non-de novo AML or advanced myelodysplastic syndromes: influence of GvHD and donor lymphocyte infusions on long-term outcome.
    Bone Marrow Transplant. 2017 Oct 9. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  18. YOSHIMURA K, Yano I, Yamamoto T, Kawanishi M, et al
    Population pharmacokinetics and pharmacodynamics of mycophenolic acid using the prospective data in patients undergoing hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Oct 9. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  19. GERULL S, Denhaerynck K, Chalandon Y, Halter JP, et al
    Lack of association between relationship status and clinical outcome in allogeneic stem cell transplantation-the Swiss Transplant Cohort Study.
    Bone Marrow Transplant. 2017 Oct 9. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  20. CHO C, Hsu M, Barba P, Maloy MA, et al
    Long-term prognosis for 1-year relapse-free survivors of CD34+ cell-selected allogeneic hematopoietic stem cell transplantation: a landmark analysis.
    Bone Marrow Transplant. 2017 Oct 9. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  21. RE A, Gini G, Rupolo M, Levis A, et al
    Early consolidation with high-dose therapy and autologous stem cell transplantation is a feasible and effective treatment option in HIV-associated non-Hodgkin lymphoma at high risk.
    Bone Marrow Transplant. 2017 Oct 9. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  22. KROGER N, Bishop M, Giralt S, Wayne A, et al
    Third International workshop on the biology, prevention, and treatment of relapse after stem cell transplantation.
    Bone Marrow Transplant. 2017 Oct 9. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  23. KHOSLA J, Yeh AC, Spitzer TR, Dey BR, et al
    Hematopoietic stem cell transplant-associated thrombotic microangiopathy: current paradigm and novel therapies.
    Bone Marrow Transplant. 2017 Oct 2. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  24. GALIENI P, Troiani E, Bigazzi C, Mazzotta S, et al
    Modified BEAM as conditioning regimen for lymphoma patients undergoing autologous hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Oct 2. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  25. LIU C, Frank DN, Horch M, Chau S, et al
    Associations between acute gastrointestinal GvHD and the baseline gut microbiota of allogeneic hematopoietic stem cell transplant recipients and donors.
    Bone Marrow Transplant. 2017 Oct 2. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


    September 2017
  26. MONTEFUSCO V, Mussetti A, Rezzonico F, Maura F, et al
    Allogeneic stem cell transplantation and subsequent treatments as a comprehensive strategy for long-term survival of multiple myeloma patients.
    Bone Marrow Transplant. 2017 Sep 11. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  27. ALMICI C, Skert C, Bruno B, Bianchetti A, et al
    Circulating endothelial cell count: a reliable marker of endothelial damage in patients undergoing hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Sep 11. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  28. SCHEID C, de Wreede L, van Biezen A, Koenecke C, et al
    Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation: a retrospective analysis of the EBMT chronic malignancies working party.
    Bone Marrow Transplant. 2017 Sep 11. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  29. KUBA K, Esser P, Mehnert A, Johansen C, et al
    Depression and anxiety following hematopoietic stem cell transplantation: a prospective population-based study in Germany.
    Bone Marrow Transplant. 2017 Sep 11. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  30. KORDELAS L, Buttkereit U, Lindemann M, Koldehoff M, et al
    alphabeta-T-cell depleted donor lymphocyte infusion for leukemia relapse after allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2017 Sep 4. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  31. MALOGOLOWKIN MH, Hemmer MT, Le-Rademacher J, Hale GA, et al
    Outcomes following autologous hematopoietic stem cell transplant for patients with relapsed Wilms' tumor: a CIBMTR retrospective analysis.
    Bone Marrow Transplant. 2017 Sep 4. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  32. DISPENZIERI A, D'Souza A, Gertz MA, Laumann K, et al
    A phase 1 trial of 90Y-Zevalin radioimmunotherapy with autologous stem cell transplant for multiple myeloma.
    Bone Marrow Transplant. 2017 Sep 4. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  33. SUGIYAMA M, Iguchi A, Yamada M, Terashita Y, et al
    Successful bone marrow transplantation in two sisters with activated phosphoinositide 3-kinase delta syndrome 2.
    Bone Marrow Transplant. 2017 Sep 4. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  34. MARTIN M, Fornecker LM, Marcellin L, Mousseaux E, et al
    Acute and fatal cardiotoxicity following high-dose cyclophosphamide in a patient undergoing autologous stem cell transplantation for systemic sclerosis despite satisfactory cardiopulmonary screening.
    Bone Marrow Transplant. 2017 Sep 4. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  35. MEHDI A, Rybicki L, Mossad S, Yurch M, et al
    Impact of cigarette smoking on survival after myeloablative allogeneic hematopoietic stem cell transplantation and contribution of invasive fungal infection.
    Bone Marrow Transplant. 2017 Sep 4. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  36. MODI D, Deol A, Kim S, Ayash L, et al
    Age does not adversely influence outcomes among patients older than 60 years who undergo allogeneic hematopoietic stem cell transplant for AML and myelodysplastic syndrome.
    Bone Marrow Transplant. 2017 Sep 4. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


    August 2017
  37. HENRY M, Valentini RP, Savasan S
    Thrombotic microangiopathy associated with monoclonal gammopathy following autologous hematopoietic stem cell transplantation for neuroblastoma in a young child.
    Bone Marrow Transplant. 2017 Aug 21. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  38. PEI XY, Zhao XY, Xu LP, Wang Y, et al
    Immune reconstitution in patients with acquired severe aplastic anemia after haploidentical stem cell transplantation.
    Bone Marrow Transplant. 2017 Aug 14. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  39. KUMAR L, Gogi R, Patel AK, Mookerjee A, et al
    Multiple myeloma with extramedullary disease: impact of autologous stem cell transplantation on outcome.
    Bone Marrow Transplant. 2017 Aug 14. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  40. FREEMAN AT, Stover AM, Grover NS, Shea TC, et al
    Patient perspectives on physical function after allogeneic hematopoietic stem cell transplantation: a qualitative study.
    Bone Marrow Transplant. 2017 Aug 7. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  41. OGATA M, Oshima K, Ikebe T, Takano K, et al
    Clinical characteristics and outcome of human herpesvirus-6 encephalitis after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Aug 7. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  42. LAHTEENMAKI K, Wacklin P, Taskinen M, Tuovinen E, et al
    Haematopoietic stem cell transplantation induces severe dysbiosis in intestinal microbiota of paediatric ALL patients.
    Bone Marrow Transplant. 2017 Aug 7. doi: 10.1038/bmt.2017.
    PubMed     Text format    


    July 2017
  43. GEETHAKUMARI PR, Leiby B, Nair R, Alpdogan SO, et al
    Higher rates of relapse in maternal recipients of haploidentical hematopoietic stem cell transplantation from adult offspring donors for AML and myelodysplastic syndrome.
    Bone Marrow Transplant. 2017 Jul 31. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  44. BEZINELLI LM, Eduardo FP, de Carvalho DLC, Dos Santos Ferreira CE, et al
    Therapeutic salivary monitoring of IV busulfan in patients undergoing hematopoietic stem cell transplantation: a pilot study.
    Bone Marrow Transplant. 2017 Jul 24. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  45. BALDUZZI A, Dalle JH, Jahnukainen K, von Wolff M, et al
    Fertility preservation issues in pediatric hematopoietic stem cell transplantation: practical approaches from the consensus of the Pediatric Diseases Working Party of the EBMT and the International BFM Study Group.
    Bone Marrow Transplant. 2017 Jul 24. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  46. TREMBLAY D, Lancman G, Moshier E, Bar N, et al
    Outcomes of salvage autologous stem cell transplantation for multiple myeloma with cytopenias and exposure to novel agents.
    Bone Marrow Transplant. 2017 Jul 24. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  47. ARUN M, Brauneis D, Doros G, Shelton AC, et al
    The incidence of atrial fibrillation among patients with AL amyloidosis undergoing high-dose melphalan and stem cell transplantation: experience at a single institution.
    Bone Marrow Transplant. 2017 Jul 24. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  48. O'DONGHAILE D, O'Flaherty N, Field S
    Early hepatitis E infection in an unrelated hematopoietic progenitor stem cell donor.
    Bone Marrow Transplant. 2017 Jul 17. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  49. ROTZ SJ, Dandoy CE, Taylor MD, Jodele S, et al
    Long-term systolic function in children and young adults after hematopoietic stem cell transplant.
    Bone Marrow Transplant. 2017 Jul 17. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  50. KAWAMURA K, Kanda J, Fuji S, Murata M, et al
    Impact of the presence of HLA 1-locus mismatch and the use of low-dose antithymocyte globulin in unrelated bone marrow transplantation.
    Bone Marrow Transplant. 2017 Jul 17. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  51. BARROSO KSN, Kaufman J, Brunetta DM, de Carvalho Araujo FM, et al
    Dengue encephalitis in allogenic hematopoietic stem cell transplantation recipient.
    Bone Marrow Transplant. 2017 Jul 17. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  52. FAIVRE L, Boucher H, Zerbib R, Domet T, et al
    Cord blood attached segment: is this a relevant quality control to predict a good hematopoietic stem cell graft?
    Bone Marrow Transplant. 2017 Jul 10. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  53. BACHEGOWDA LS, Shah MV, Veltri LW, Tanase A, et al
    HLA-mismatched bone marrow transplantation in severe aplastic anemia.
    Bone Marrow Transplant. 2017 Jul 10. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  54. CLAVEAU JS, LeBlanc R, Ahmad I, Ferreira J, et al
    Cerebral adenovirus endotheliitis presenting as posterior reversible encephalopathy syndrome after allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2017 Jul 10. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  55. TAKEKIYO T, Dozono K, Nara S, Murayama Y, et al
    Gender differences in physical function and muscle mass change in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Jul 10. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  56. LIU Z, Zhang Y, Xiao H, Yao Z, et al
    Cotransplantation of bone marrow-derived mesenchymal stem cells in haploidentical hematopoietic stem cell transplantation in patients with severe aplastic anemia: an interim summary for a multicenter phase II trial results.
    Bone Marrow Transplant. 2017;52:1080.
    PubMed     Text format     Abstract available


  57. MILLER PDE, de Silva TI, Skinner R, Gilleece M, et al
    Routine vaccination practice after adult and paediatric allogeneic haematopoietic stem cell transplant: a survey of UK NHS programmes.
    Bone Marrow Transplant. 2017;52:1082.
    PubMed     Text format     Abstract available


  58. ROBIN M, Porcher R, Zinke-Cerwenka W, van Biezen A, et al
    Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT.
    Bone Marrow Transplant. 2017;52:1081.
    PubMed     Text format     Abstract available


    June 2017
  59. SCHUMACHER A, Sauerland C, Silling G, Berdel WE, et al
    Development of quality of life in patients undergoing allogeneic stem cell transplantation with regard to anxiety, depression and resilience.
    Bone Marrow Transplant. 2017 Jun 26. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  60. TICHELLI A, Gerull S, Holbro A, Buser A, et al
    Inability to work and need for disability pension among long-term survivors of hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Jun 26. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  61. SHIMOMURA Y, Hara M, Hashimoto H, Ishikawa T, et al
    Elevated bone marrow eosinophil count is associated with high incidence of severe acute GvHD after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Jun 19. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  62. GRIGG A, Butcher B, Khodr B, Bajel A, et al
    An individualised risk-adapted protocol of pre- and post transplant zoledronic acid reduces bone loss after allogeneic stem cell transplantation: results of a phase II prospective trial.
    Bone Marrow Transplant. 2017 Jun 19. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  63. DECEMBRINO N, Comelli A, Genco F, Vitullo A, et al
    Toxoplasmosis disease in paediatric hematopoietic stem cell transplantation: do not forget it still exists.
    Bone Marrow Transplant. 2017 Jun 12. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  64. CHABANNON C, Bijou F, Grouin JM, Drillat P, et al
    The choice of in-hospital or home administration for plerixafor injection to poor mobilizers has no adverse consequence on subsequent hematopoietic stem cell harvest.
    Bone Marrow Transplant. 2017 Jun 5. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  65. UNNIKRISHNAN A, Glover SC, Norkina O, Wingard JR, et al
    Complete resolution of severe ulcerative colitis after haploidentical hematopoietic stem cell transplantation followed by post-transplant high-dose cyclophosphamide.
    Bone Marrow Transplant. 2017 Jun 5. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  66. NECCHI A, Lo Vullo S, Rosti G, Badoglio M, et al
    Administration of high-dose chemotherapy with stem cell support in patients 40 years of age or older with advanced germ cell tumours: a retrospective study from the European Society for Blood and Marrow Transplantation database.
    Bone Marrow Transplant. 2017 Jun 5. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  67. KASSAM S, Chernucha E, O'Neill A, Hemmaway C, et al
    High-dose chemotherapy and autologous stem cell transplantation for primary central nervous system lymphoma: a multi-centre retrospective analysis from the United Kingdom.
    Bone Marrow Transplant. 2017 Jun 5. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  68. GROS FX, Cazaubiel T, Forcade E, Lechevalier N, et al
    Severe acute GvHD following administration of ipilimumab for early relapse of AML after haploidentical stem cell transplantation.
    Bone Marrow Transplant. 2017 Jun 5. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  69. FLANK J, Sparavalo J, Vol H, Hagen L, et al
    The burden of chemotherapy-induced nausea and vomiting in children receiving hematopoietic stem cell transplantation conditioning: a prospective study.
    Bone Marrow Transplant. 2017 Jun 5. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  70. SALEM R, Massoud R, Haffar B, Mahfouz R, et al
    Dynamics of molecular response in AML patients with NPM1 and FLT3 mutations undergoing allogeneic stem cell transplant.
    Bone Marrow Transplant. 2017 Jun 5. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  71. GIACCONE L, Festuccia M, Zallio F, Sorasio R, et al
    Long-term follow-up of allogeneic stem cell transplantation in relapsed/refractory Hodgkin lymphoma.
    Bone Marrow Transplant. 2017 Jun 5. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  72. SOLANO C, Gimenez E, Pinana JL, Hernandez-Boluda JC, et al
    When should preemptive antiviral therapy for active CMV infection be withdrawn from allogeneic stem cell transplant recipients?
    Bone Marrow Transplant. 2017 Jun 5. doi: 10.1038/bmt.2017.
    PubMed     Text format    


    May 2017
  73. FARGE D, Burt RK, Oliveira MC, Mousseaux E, et al
    Cardiopulmonary assessment of patients with systemic sclerosis for hematopoietic stem cell transplantation: recommendations from the European Society for Blood and Marrow Transplantation Autoimmune Diseases Working Party and collaborating partners.
    Bone Marrow Transplant. 2017 May 22. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  74. BENTO L, Boumendil A, Finel H, Le Gouill S, et al
    Radioimmunotherapy-augmented BEAM chemotherapy vs BEAM alone as the high-dose regimen for autologous stem cell transplantation (ASCT) in relapsed follicular lymphoma (FL): a retrospective study of the EBMT Lymphoma Working Party.
    Bone Marrow Transplant. 2017 May 22. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  75. JETHAVA YS, Sica S, Savani B, Socola F, et al
    Conditioning regimens for allogeneic hematopoietic stem cell transplants in acute myeloid leukemia.
    Bone Marrow Transplant. 2017 May 15. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  76. MEHTA RS, Cao Q, Holtan S, MacMillan ML, et al
    Upper GI GVHD: similar outcomes to other grade II graft-versus-host disease.
    Bone Marrow Transplant. 2017 May 15. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  77. CHEE L, Tacey M, Lim B, Lim A, et al
    Pre-transplant ferritin, albumin and haemoglobin are predictive of survival outcome independent of disease risk index following allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2017 May 15. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  78. MOHANAN E, Panetta JC, Lakshmi KM, Edison ES, et al
    Population pharmacokinetics of fludarabine in patients with aplastic anemia and Fanconi anemia undergoing allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 May 8. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  79. GUENTHER A, Losch E, Schiessl M, Schrauder A, et al
    Dental status does not predict infection during stem cell transplantation: a single-center survey.
    Bone Marrow Transplant. 2017 May 8. doi: 10.1038/bmt.2017.
    PubMed     Text format    


    April 2017
  80. HAMBLIN A, Greenfield DM, Gilleece M, Salooja N, et al
    Provision of long-term monitoring and late effects services following adult allogeneic haematopoietic stem cell transplant: a survey of UK NHS-based programmes.
    Bone Marrow Transplant. 2017 Apr 24. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  81. FOELL J, Pfirstinger B, Rehe K, Wolff D, et al
    Haploidentical stem cell transplantation with CD3+-/CD19+- depleted peripheral stem cells for patients with advanced stage sickle cell disease and no alternative donor: results of a pilot study.
    Bone Marrow Transplant. 2017 Apr 24. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  82. SCHORB E, Fox CP, Fritsch K, Isbell L, et al
    High-dose thiotepa-based chemotherapy with autologous stem cell support in elderly patients with primary central nervous system lymphoma: a European retrospective study.
    Bone Marrow Transplant. 2017 Apr 24. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  83. DVORAK CC, Patel K, Puck JM, Wahlstrom J, et al
    Unconditioned unrelated donor bone marrow transplantation for IL7Ralpha- and Artemis-deficient SCID.
    Bone Marrow Transplant. 2017 Apr 24. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  84. WEISCHENDORFF S, Kielsen K, Sengelov H, Jordan K, et al
    Associations between levels of insulin-like growth factor 1 and sinusoidal obstruction syndrome after allogeneic haematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Apr 24. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  85. WONG SW, Larivee D, Warner M, Sprague KA, et al
    Stem cell transplantation in patients with systemic AL amyloidosis referred for transplant after suboptimal responses to bortezomib-based initial therapy.
    Bone Marrow Transplant. 2017 Apr 10. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  86. SIMONIN M, Dalissier A, Labopin M, Willasch A, et al
    More chronic GvHD and non-relapse mortality after peripheral blood stem cell compared with bone marrow in hematopoietic transplantation for paediatric acute lymphoblastic leukemia: a retrospective study on behalf of the EBMT Paediatric Diseases Workin
    Bone Marrow Transplant. 2017 Apr 10. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  87. TANDON N, Muchtar E, Sidana S, Dispenzieri A, et al
    Revisiting conditioning dose in newly diagnosed light chain amyloidosis undergoing frontline autologous stem cell transplant: impact on response and survival.
    Bone Marrow Transplant. 2017 Apr 10. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  88. ROTZ SJ, Ryan TD, Jodele S, Jefferies JL, et al
    The injured heart: early cardiac effects of hematopoietic stem cell transplantation in children and young adults.
    Bone Marrow Transplant. 2017 Apr 10. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  89. LIOU A, Wahlstrom JT, Dvorak CC, Horn BN, et al
    Safety of pre-emptive donor lymphocyte infusions (DLI) based on mixed chimerism (MC) in peripheral blood or bone marrow subsets in children undergoing hematopoietic stem cell transplant (HSCT) for hematologic malignancies.
    Bone Marrow Transplant. 2017 Apr 10. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  90. EL CHEIKH J, Massoud R, Abudalle I, Haffar B, et al
    Nivolumab salvage therapy before or after allogeneic stem cell transplantation in Hodgkin lymphoma.
    Bone Marrow Transplant. 2017 Apr 10. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  91. GARNIER A, Guillaume T, Peterlin P, Bene MC, et al
    Second-degree relative donors for T-replete haploidentical allogeneic stem cell transplantation with high-dose post-transplant cyclophosphamide: toward crossing the major HLA barrier.
    Bone Marrow Transplant. 2017 Apr 3. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  92. SONG JS, London WB, Hawryluk EB, Guo D, et al
    Risk of melanocytic nevi and nonmelanoma skin cancer in children after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Apr 3. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  93. BILL M, Jentzsch M, Grimm J, Schubert K, et al
    Prognostic impact of the European LeukemiaNet standardized reporting system in older AML patients receiving stem cell transplantation after non-myeloablative conditioning.
    Bone Marrow Transplant. 2017 Apr 3. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  94. ARTECHE-LOPEZ A, Kreutzman A, Alegre A, Sanz Martin P, et al
    Multiple myeloma patients in long-term complete response after autologous stem cell transplantation express a particular immune signature with potential prognostic implication.
    Bone Marrow Transplant. 2017 Apr 3. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


    March 2017
  95. ISAEV AA, Deev RV, Kuliev A, Plaxa IL, et al
    First experience of hematopoietic stem cell transplantation treatment of Shwachman-Diamond syndrome using unaffected HLA-matched sibling donor produced through preimplantation HLA typing.
    Bone Marrow Transplant. 2017 Mar 27. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  96. BRESTERS D, Wanders DC, Louwerens M, Ball LM, et al
    Permanent diffuse alopecia after haematopoietic stem cell transplantation in childhood.
    Bone Marrow Transplant. 2017 Mar 20. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  97. OH A, Patel PR, Aardsma N, Mehendale SR, et al
    Non-myeloablative allogeneic stem cell transplant with post-transplant cyclophosphamide cures the first adult patient with congenital dyserythropoietic anemia.
    Bone Marrow Transplant. 2017 Mar 20. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  98. KAWAJIRI A, Fuji S, Tanaka Y, Kono C, et al
    Clinical impact of hyperglycemia on days 0-7 after allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2017 Mar 20. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  99. BURMAN J, Kirgizov K, Carlson K, Badoglio M, et al
    Autologous hematopoietic stem cell transplantation for pediatric multiple sclerosis: a registry-based study of the Autoimmune Diseases Working Party (ADWP) and Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transp
    Bone Marrow Transplant. 2017 Mar 20. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  100. LUSSANA F, Di Ianni M, Rambaldi A
    Tregs: hype or hope for allogeneic hematopoietic stem cell transplantation?
    Bone Marrow Transplant. 2017 Mar 20. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  101. SAAD A, Lamb LS
    Ex vivo T-cell depletion in allogeneic hematopoietic stem cell transplant: past, present and future.
    Bone Marrow Transplant. 2017 Mar 20. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  102. MORGENSTERN DA, Gray P, Prudhoe A, Watts M, et al
    Developing quality assurance for pediatric autologous stem cell transplants in England: results of a 3-year national audit of activity and engraftment by treatment centre.
    Bone Marrow Transplant. 2017 Mar 13. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  103. DOTOLI GM, De Santis GC, Orellana MD, de Lima Prata K, et al
    Mesenchymal stromal cell infusion to treat steroid-refractory acute GvHD III/IV after hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Mar 13. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  104. CETIN M, Akyol G, Gonen ZB, Keklik M, et al
    Additional infusions of mesenchymal stem cells improve response rate in multidrug-resistant GvHD patients.
    Bone Marrow Transplant. 2017 Mar 13. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  105. HO C, Zacharin M
    Fertility preservation in an adolescent boy: inducing puberty and spermatogenesis prior to elective, non-urgent bone marrow transplantation.
    Bone Marrow Transplant. 2017 Mar 13. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  106. PASSWEG JR, Baldomero H, Bader P, Bonini C, et al
    Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report.
    Bone Marrow Transplant. 2017 Mar 13. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  107. DALLE JH, Lucchini G, Balduzzi A, Ifversen M, et al
    State-of-the-art fertility preservation in children and adolescents undergoing haematopoietic stem cell transplantation: a report on the expert meeting of the Paediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transp
    Bone Marrow Transplant. 2017 Mar 13. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  108. NATORI Y, Humar A, Lipton J, Kim DD, et al
    A pilot randomized trial of adjuvanted influenza vaccine in adult allogeneic hematopoietic stem cell transplant recipients.
    Bone Marrow Transplant. 2017 Mar 6. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  109. COOLING L, Sankar A, Mody R, Yanik G, et al
    A severe umbilical cord stem cell infusion reaction due to dextran in an atopic pediatric patient.
    Bone Marrow Transplant. 2017 Mar 6. doi: 10.1038/bmt.2017.
    PubMed     Text format    


    February 2017
  110. O'HARE P, Lucchini G, Cummins M, Veys P, et al
    Allogeneic stem cell transplantation for refractory acute myeloid leukemia in pediatric patients: the UK experience.
    Bone Marrow Transplant. 2017 Feb 20. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  111. LUM SH, Miller WP, Jones S, Poulton K, et al
    Changes in the incidence, patterns and outcomes of graft failure following hematopoietic stem cell transplantation for Hurler syndrome.
    Bone Marrow Transplant. 2017 Feb 20. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  112. IGLESIAS L, Perera MM, Torres-Minana L, Pena-Lopez MJ, et al
    CMV viral load in bronchoalveolar lavage for diagnosis of pneumonia in allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Feb 20. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  113. BOURLON C, Alamoudi S, Kumar D, Viswabandya A, et al
    A short tale of blood, kidney and brain: BK virus encephalitis in an allogeneic stem cell transplant recipient.
    Bone Marrow Transplant. 2017 Feb 20. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  114. BLUM V, Heini AD, Novak U, Taleghani BM, et al
    Hematopoietic stem cell remobilization with vinorelbine and filgrastim in AML.
    Bone Marrow Transplant. 2017 Feb 13. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  115. TANAKA Y, Kurosawa S, Tajima K, Tanaka T, et al
    Increased incidence of oral and gastrointestinal secondary cancer after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Feb 13. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  116. YAMASHITA T, Ikegame K, Kojima H, Tanaka H, et al
    Effective desensitization of donor-specific HLA antibodies using platelet transfusion bearing targeted HLA in a case of HLA-mismatched allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2017 Feb 6. doi: 10.1038/bmt.2017.
    PubMed     Text format    


    January 2017
  117. BERRO M, Palau Nagore MV, Rivas MM, Longo P, et al
    Transforming growth factor-beta1 functional polymorphisms in myeloablative sibling hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Jan 30. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  118. LE BRIS Y, Guillaume T, Menard A, Illiaquer M, et al
    Lymphocyte expansion after unrelated cord blood allogeneic stem cell transplantation in adults.
    Bone Marrow Transplant. 2017 Jan 30. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  119. LEON-RODRIGUEZ E, Rivera-Franco MM, Campos-Castro A
    Is day +1 omission of methotrexate associated with higher incidence of acute GvHD in hematopoietic stem cell transplantation?
    Bone Marrow Transplant. 2017 Jan 23. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  120. ROUX C, Tifratene K, Socie G, Galambrun C, et al
    Outcome after failure of allogeneic hematopoietic stem cell transplantation in children with acute leukemia: a study by the societe Francophone de greffe de moelle et de therapie cellulaire (SFGM-TC).
    Bone Marrow Transplant. 2017 Jan 23. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  121. FUJI S, Maeshima AM, Kim SW, Fukuda T, et al
    Significant nutrient deposition in the liver after allogeneic hematopoietic stem cell transplantation: pathological analysis of 25 autopsy cases.
    Bone Marrow Transplant. 2017 Jan 23. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  122. PUNDOLE X, Cheema HI, Petitto GS, Lopez-Olivo MA, et al
    Prevention and treatment of bone loss and fractures in patients undergoing a hematopoietic stem cell transplant: a systematic review and meta-analysis.
    Bone Marrow Transplant. 2017 Jan 23. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  123. MILLER PD, de Silva TI, Skinner R, Gilleece M, et al
    Routine vaccination practice after adult and paediatric allogeneic haematopoietic stem cell transplant: a survey of UK NHS programmes.
    Bone Marrow Transplant. 2017 Jan 23. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  124. BATTIPAGLIA G, Labopin M, Candoni A, Fanin R, et al
    Risk of sinusoidal obstruction syndrome in allogeneic stem cell transplantation after prior gemtuzumab ozogamicin treatment: a retrospective study from the Acute Leukemia Working Party of the EBMT.
    Bone Marrow Transplant. 2017 Jan 16. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  125. RADFORD J, McKay P, Malladi R, Johnson R, et al
    Treatment pathways and resource use associated with recurrent Hodgkin lymphoma after autologous stem cell transplantation.
    Bone Marrow Transplant. 2017 Jan 16. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  126. BOUDIN L, Goncalves A, Sabatier R, Moretta J, et al
    Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Jan 16. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  127. SORGE C, Pereboeva L, Westin E, Harris WT, et al
    Pulmonary complications post hematopoietic stem cell transplant in dyskeratosis congenita: analysis of oxidative stress in lung fibroblasts.
    Bone Marrow Transplant. 2017 Jan 16. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  128. GLEZERMAN IG, Devlin S, Maloy M, Bui M, et al
    Long term renal survival in patients undergoing T-Cell depleted versus conventional hematopoietic stem cell transplants.
    Bone Marrow Transplant. 2017 Jan 16. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  129. CAI WZ, Cen JN, Chen J, Chen F, et al
    Major molecular response prior to allogeneic hematopoietic stem cell transplantation predicts better outcome in adult Philadelphia-positive acute lymphoblastic leukemia in first remission.
    Bone Marrow Transplant. 2017 Jan 16. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  130. BAUMGARTNER A, Bargetzi A, Zueger N, Bargetzi M, et al
    Revisiting nutritional support for allogeneic hematologic stem cell transplantation-a systematic review.
    Bone Marrow Transplant. 2017 Jan 9. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  131. GROSSO D, Johnson E, Colombe B, Alpdogan O, et al
    Acquired uniparental disomy in chromosome 6p as a feature of relapse after T-cell replete haploidentical hematopoietic stem cell transplantation using cyclophosphamide tolerization.
    Bone Marrow Transplant. 2017 Jan 9. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  132. PITTMAN C, Hsieh MM, Coles W, Tisdale JF, et al
    Reversal of pre-capillary pulmonary hypertension in a patient with sickle cell anemia who underwent haploidentical peripheral blood stem cell transplantation.
    Bone Marrow Transplant. 2017 Jan 9. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  133. UTRIAINEN P, Vatanen A, Toiviainen-Salo S, Saarinen-Pihkala U, et al
    Skeletal outcome in long-term survivors of childhood high-risk neuroblastoma treated with high-dose therapy and autologous stem cell rescue.
    Bone Marrow Transplant. 2017 Jan 9. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  134. FUJIWARA H, Fuji S, Wake A, Kato K, et al
    Dismal outcome of allogeneic hematopoietic stem cell transplantation for relapsed adult T-cell leukemia/lymphoma, a Japanese nation-wide study.
    Bone Marrow Transplant. 2017 Jan 9. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  135. DULERY R, Nibourel O, Gauthier J, Elsermans V, et al
    Impact of Wilms' tumor 1 expression on outcome of patients undergoing allogeneic stem cell transplantation for AML.
    Bone Marrow Transplant. 2017 Jan 9. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  136. SCHULTZE-FLOREY RE, Tischer S, Kuhnau W, Heim A, et al
    Persistent recipient-derived human adenovirus (HAdV)-specific T cells promote HAdV control after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Jan 9. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  137. LIU Z, Zhang Y, Xiao H, Yao Z, et al
    Cotransplantation of bone marrow-derived mesenchymal stem cells in haploidentical hematopoietic stem cell transplantation in patients with severe aplastic anemia: an interim summary for a multicenter phase II trial results.
    Bone Marrow Transplant. 2017 Jan 9. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  138. GAUTHIER J, Castagna L, Garnier F, Guillaume T, et al
    Reduced-intensity and non-myeloablative allogeneic stem cell transplantation from alternative HLA-mismatched donors for Hodgkin lymphoma: a study by the French Society of Bone Marrow Transplantation and Cellular Therapy.
    Bone Marrow Transplant. 2017 Jan 9. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  139. MCDUFFEE E, Aue G, Cook L, Ramos-Delgado C, et al
    Tumor regression concomitant with steroid-refractory GvHD highlights the pitfalls of PD-1 blockade following allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Jan 9. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  140. CARRE M, Thiebaut-Bertrand A, Larrat S, Leroy V, et al
    Fatal autochthonous fulminant hepatitis E early after allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2017 Jan 9. doi: 10.1038/bmt.2016.
    PubMed     Text format    


    December 2016
  141. BARABAN EG, Hu S, Hui P, Podoltsev N, et al
    Tissue-based chimerism analysis enhances detection of donor-derived neoplasia in allogeneic stem cell transplant patients.
    Bone Marrow Transplant. 2016 Dec 19. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  142. STENEHJEM JS, Smeland KB, Murbraech K, Holte H, et al
    Diffusing capacity impairment is prevalent in long-term lymphoma survivors after high-dose therapy with autologous stem cell transplantation.
    Bone Marrow Transplant. 2016 Dec 19. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  143. PFEIFFER TM, Rotz SJ, Ryan TD, Hirsch R, et al
    Pericardial effusion requiring surgical intervention after stem cell transplantation: a case series.
    Bone Marrow Transplant. 2016 Dec 19. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  144. MEISSNER J, Finel H, Dietrich S, Boumendil A, et al
    Autologous hematopoietic stem cell transplantation for intravascular large B-cell lymphoma: the European Society for Blood and Marrow Transplantation experience.
    Bone Marrow Transplant. 2016 Dec 19. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  145. WILLEMSE SB, Bezuur DL, Blom P, Kneppers E, et al
    Hepatitis E virus infection and hepatic GvHD in allogeneic hematopoietic stem cell transplantation recipients.
    Bone Marrow Transplant. 2016 Dec 19. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  146. BUCCISANO F, Maurillo L, Piciocchi A, Del Principe MI, et al
    Pre-transplant persistence of minimal residual disease does not contraindicate allogeneic stem cell transplantation for adult patients with acute myeloid leukemia.
    Bone Marrow Transplant. 2016 Dec 12. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  147. GHAZIKHANIAN SE, Dorfman CS, Somers TJ, O'Sullivan ML, et al
    Cognitive problems following hematopoietic stem cell transplant: relationships with sleep, depression and fatigue.
    Bone Marrow Transplant. 2016 Dec 12. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  148. FUJI S, Loffler J, Savani BN, Einsele H, et al
    Hyperglycemia as a possible risk factor for mold infections-the potential preventative role of intensified glucose control in allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2016 Dec 12. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  149. KORNBLIT B, Muller K
    Sensing danger: toll-like receptors and outcome in allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2016 Dec 12. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  150. POURHASSAN H, DeFor T, Trottier B, Dolan M, et al
    MDS disease characteristics, not donor source, predict hematopoietic stem cell transplant outcomes.
    Bone Marrow Transplant. 2016 Dec 12. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  151. LEGRAND F, Le Floch AC, Granata A, Furst S, et al
    Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation for high-risk AML.
    Bone Marrow Transplant. 2016 Dec 12. doi: 10.1038/bmt.2016.
    PubMed     Text format    


    November 2016
  152. ALBRING JC, Inselmann S, Sauer T, Schliemann C, et al
    PD-1 checkpoint blockade in patients with relapsed AML after allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2016 Nov 28. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  153. MACHIDA S, Onizuka M, Toyosaki M, Aoyama Y, et al
    Danaparoid reduces the incidence of hematopoietic stem cell transplantation-associated thrombotic microangiopathy.
    Bone Marrow Transplant. 2016 Nov 28. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  154. GHEZ D, Fortpied C, Mounier N, Carde P, et al
    First-line escalated BEACOPP does not hinder stem cell collection and transplantation strategy in patients with relapsed/refractory Hodgkin's lymphoma.
    Bone Marrow Transplant. 2016 Nov 28. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  155. AL JEFRI AH, Abujazar H, Al-Ahmari A, Al Rawas A, et al
    Veno-occlusive disease/sinusoidal obstruction syndrome after haematopoietic stem cell transplantation: Middle East/North Africa regional consensus on prevention, diagnosis and management.
    Bone Marrow Transplant. 2016 Nov 28. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  156. ROBINSON SP
    Diffuse large B-cell lymphoma: the challenge of relapse after an autologous stem cell transplant.
    Bone Marrow Transplant. 2016 Nov 21. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  157. ALSULTAN A, Essa M, Alsudairy R
    Hematopoietic stem cell transplantation in FANCJ/BRIP1 fanconi anemia.
    Bone Marrow Transplant. 2016 Nov 21. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  158. FERNANDEZ DE LARREA C, Davila J, Isola I, Ocio EM, et al
    Absence of spontaneous response improvement beyond day +100 after autologous stem cell transplantation in multiple myeloma.
    Bone Marrow Transplant. 2016 Nov 21. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  159. FIFE BL, Von Ah DM, Spath ML, Weaver MT, et al
    Preliminary efficacy of a brief family intervention to prevent declining quality of life secondary to parental bone marrow transplantation.
    Bone Marrow Transplant. 2016 Nov 21. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  160. GRESCH B, Kirsch M, Fierz K, Halter JP, et al
    Medication nonadherence to immunosuppressants after adult allogeneic haematopoietic stem cell transplantation: a multicentre cross-sectional study.
    Bone Marrow Transplant. 2016 Nov 14. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  161. WEDRYCHOWICZ A, Wojtys J, Starzyk J
    Anti-Muellerian hormone (AMH) as only possible marker in the assessment of ovarian function and reserve after hematopoietic stem cell transplantation (HSCT) in prepubertal girls, young females with composed hypogonadism and females receiving hormonal
    Bone Marrow Transplant. 2016 Nov 14. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  162. ISSARAGRISIL S, Cheng-Hwai T, Bunworasate U, Su-Peng Y, et al
    Cyclophosphamide vs salvage chemotherapy plus G-CSF as chemo-mobilization in Asian patients undergoing autologous hematopoietic stem cell transplant.
    Bone Marrow Transplant. 2016 Nov 14. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  163. LEE MH, Jang JH, Min HJ, Jang HI, et al
    Predictors of general discomfort, limitations in activities of daily living and intention of a second donation in unrelated hematopoietic stem cell donation.
    Bone Marrow Transplant. 2016 Nov 7. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  164. ROBIN M, Porcher R, Zinke-Cerwenka W, van Biezen A, et al
    Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT.
    Bone Marrow Transplant. 2016;.
    PubMed     Text format     Abstract available


  165. PASSWEG JR, Baldomero H, Bader P, Bonini C, et al
    Impact of drug development on the use of stem cell transplantation: a report by the European Society for Blood and Marrow Transplantation (EBMT).
    Bone Marrow Transplant. 2016 Nov 7. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  166. SUGITA J, Miyamoto T, Kawashima N, Hatsumi N, et al
    Prior history of HLA-mismatched stem cell transplantation is a risk factor for graft failure in HLA-haploidentical transplantation.
    Bone Marrow Transplant. 2016 Nov 7. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  167. KHARFAN-DABAJA MA, Parody R, Perkins J, Lopez-Godino O, et al
    Tacrolimus plus sirolimus with or without ATG as GVHD prophylaxis in HLA-mismatched unrelated donor allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2016 Nov 7. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


    October 2016
  168. BIAN Z, Liu J, Xu LP, Chang YJ, et al
    Association of Epstein-Barr virus reactivation with the recovery of CD4/CD8 double-negative T lymphocytes after haploidentical hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2016 Oct 31. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  169. MA YR, Xu LP, Zhang XH, Yan CH, et al
    Comparable post-relapse outcomes between haploidentical and matched related donor allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2016 Oct 31. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  170. LI Z, Wang Y, Wang J, Zhang J, et al
    Successful haploidentical stem cell transplantation for three adults with primary hemophagocytic lymphohistiocytosis.
    Bone Marrow Transplant. 2016 Oct 24. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  171. BEN ABDEJLIL N, Belloumi D, Maammar M, El Fatimi R, et al
    Peripheral blood stem cell mobilization in multiple myeloma comparison of two consecutive regimens in a limited resources country.
    Bone Marrow Transplant. 2016 Oct 24. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  172. GAUTHIER J, Holmberg L, Wu D, Bensinger W, et al
    Minimal detectable disease confirmed by flow cytometry and poor outcome after autologous stem cell transplantation in peripheral T-Cell lymphomas.
    Bone Marrow Transplant. 2016 Oct 24. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  173. CASTAGNA L, Sarina B, Crocchiolo R, Bramanti S, et al
    Outcomes of Hodgkin lymphoma patients who relapse after allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2016 Oct 17. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  174. ROSENGREN S, Mellqvist UH, Nahi H, Forsberg K, et al
    Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation in Sweden, long-term results from all patients treated in 1994-2009.
    Bone Marrow Transplant. 2016 Oct 3. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


    September 2016
  175. CHOI YB, Yi ES, Lee JW, Sung KW, et al
    Immunosuppressive therapy versus alternative donor hematopoietic stem cell transplantation for children with severe aplastic anemia who lack an HLA-matched familial donor.
    Bone Marrow Transplant. 2016 Sep 26. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  176. FORCINA A, Baldan R, Marasco V, Cichero P, et al
    Control of infectious mortality due to carbapenemase-producing Klebsiella pneumoniae in hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2016 Sep 26. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  177. BAI L, Peters L, Xia W, Best G, et al
    Assessing pilot vial material as a surrogate for functional and phenotypic stem cell markers in cryopreserved haematopoietic stem cell product.
    Bone Marrow Transplant. 2016 Sep 26. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  178. SARACENI F, Bruno B, Lemoli RM, Meloni G, et al
    Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: a GITMO survey on 809 patients autografted in first complete remission.
    Bone Marrow Transplant. 2016 Sep 26. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  179. VAN DEN NESTE E, Schmitz N, Mounier N, Gill D, et al
    Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: an analysis of patients included in the CORAL study.
    Bone Marrow Transplant. 2016 Sep 19. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  180. CAOCCI G, Vacca A, Piras E, Serreli V, et al
    Return to normal life after hematopoietic stem cell transplantation for thalassemia: a study of patients transplanted from matched sibling donors.
    Bone Marrow Transplant. 2016 Sep 19. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  181. GATTI-MAYS ME, Manion M, Bowen LN, Brown GT, et al
    Toxoplasmosis encephalitis with immune-reconstitution inflammatory syndrome in an allogeneic stem cell transplant patient: a case report.
    Bone Marrow Transplant. 2016 Sep 19. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  182. STRAATHOF K, Anoop P, Allwood Z, Silva J, et al
    Long-term outcome following cyclosporine-related neurotoxicity in paediatric allogeneic haematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2016 Sep 19. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  183. WILLASCH AM, Salzmann-Manrique E, Krenn T, Duerken M, et al
    Treatment of relapse after allogeneic stem cell transplantation in children and adolescents with ALL: the Frankfurt experience.
    Bone Marrow Transplant. 2016 Sep 19. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  184. HUSSEIN AA, Hamidieh AA, Elhaddad A, Ramzi M, et al
    First report of pediatric hematopoietic stem cell transplantation activities in the eastern mediterranean region from 1984 to 2011: on behalf of the pediatric cancer working committee of the eastern mediterranean blood and marrow transplantation group
    Bone Marrow Transplant. 2016 Sep 12. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  185. PHILLIPS EH, Hodson A, Hermine O, Bazarbachi A, et al
    Striving to cure adult T-cell leukaemia/lymphoma: a role for allogeneic stem cell transplant?
    Bone Marrow Transplant. 2016 Sep 12. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  186. BRAMMER JE, Saliba RM, Jorgensen JL, Ledesma C, et al
    Multi-center analysis of the effect of T-cell acute lymphoblastic leukemia subtype and minimal residual disease on allogeneic stem cell transplantation outcomes.
    Bone Marrow Transplant. 2016 Sep 12. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  187. SIRVENT A, Auquier P, Oudin C, Bertrand Y, et al
    Prevalence and risk factors of iron overload after hematopoietic stem cell transplantation for childhood acute leukemia: a LEA study.
    Bone Marrow Transplant. 2016 Sep 5. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  188. KIM M, Park J, Lee J, Jang W, et al
    Hemolytic anemia with null PKLR mutations identified using whole exome sequencing and cured by hematopoietic stem cell transplantation combined with splenectomy.
    Bone Marrow Transplant. 2016 Sep 5. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  189. RAMASWAMI R, Pria AD, Parker K, McCann S, et al
    Outcomes of autologous stem cell transplantation (ASCT) in patients with relapsed/refractory HIV-associated lymphoma.
    Bone Marrow Transplant. 2016 Sep 5. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  190. GARCIA-CADENAS I, Rivera I, Martino R, Esquirol A, et al
    Patterns of infection and infection-related mortality in patients with steroid-refractory acute graft versus host disease.
    Bone Marrow Transplant. 2016 Sep 5. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


    August 2016
  191. DEL PAPA N, Onida F, Zaccara E, Saporiti G, et al
    Autologous hematopoietic stem cell transplantation has better outcomes than conventional therapies in patients with rapidly progressive systemic sclerosis.
    Bone Marrow Transplant. 2016 Aug 22. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  192. GOMEZ-ALMAGUER D, Vazquez-Mellado A, Navarro-Cabrera JR, Abello-Polo V, et al
    The Latin American experience of allografting patients with severe aplastic anaemia: real-world data on the impact of stem cell source and ATG administration in HLA-identical sibling transplants.
    Bone Marrow Transplant. 2016 Aug 22. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  193. KOYAMA D, Ito M, Yokohata E, Watakabe K, et al
    Autoimmune-like hepatitis after allogeneic hematopoietic stem cell transplantation: humoral hepatic GvHD.
    Bone Marrow Transplant. 2016 Aug 15. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  194. MARCHESI F, Tendas A, Giannarelli D, Viggiani C, et al
    Cryotherapy reduces oral mucositis and febrile episodes in myeloma patients treated with high-dose melphalan and autologous stem cell transplant: a prospective, randomized study.
    Bone Marrow Transplant. 2016 Aug 15. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  195. O'DONNELL PV, Eapen M, Horowitz MM, Logan BR, et al
    Comparable outcomes with marrow or peripheral blood as stem cell sources for hematopoietic cell transplantation from haploidentical donors after non-ablative conditioning: a matched-pair analysis.
    Bone Marrow Transplant. 2016 Aug 15. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  196. WHANGBO J, Ritz J, Bhatt A
    Antibiotic-mediated modification of the intestinal microbiome in allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2016 Aug 15. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  197. ABOUL NOUR H, Patil N, Chewning JH, Di Stasi A, et al
    Safety of repeated un-manipulated peripheral blood stem cell haploidentical transplant for graft failure.
    Bone Marrow Transplant. 2016 Aug 15. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  198. ANDERLINI P
    Sixty as the new forty: considerations on older related stem cell donors.
    Bone Marrow Transplant. 2016 Aug 8. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  199. CHO WK, Ahn MB, Lee JW, Chung NG, et al
    Low bone mineral density in adolescents with leukemia after hematopoietic stem cell transplantation: prolonged steroid therapy for GvHD and endocrinopathy after hematopoietic stem cell transplantation might be major concerns?
    Bone Marrow Transplant. 2016 Aug 1. doi: 10.1038/bmt.2016.
    PubMed     Text format    


    July 2016
  200. CAGDAS D, Erman B, Hanoglu D, Tavil B, et al
    Course of IL-2-inducible T-cell kinase deficiency in a family: lymphomatoid granulomatosis, lymphoma and allogeneic bone marrow transplantation in one sibling; and death in the other.
    Bone Marrow Transplant. 2016 Jul 25. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  201. DEFILIPP Z, Rosand CB, Goldstein DA, Master VA, et al
    Comparable outcomes following two or three cycles of high-dose chemotherapy and autologous stem cell transplantation for patients with relapsed/refractory germ cell tumors.
    Bone Marrow Transplant. 2016 Jul 18. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  202. MAGENAU J, Westervelt P, Khaled S, McGuirk J, et al
    A multicenter trial of myeloablative clofarabine and busulfan conditioning for relapsed or primary induction failure AML not in remission at the time of allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2016 Jul 18. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  203. RIMONDO A, Crocchiolo R, El-Cheikh J, Bramanti S, et al
    The calcineurin inhibitor and the intensity of the conditioning regimen may affect the occurrence of polyomavirus-associated hemorrhagic cystitis after haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide.
    Bone Marrow Transplant. 2016 Jul 18. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  204. EHRLICH KB, Miller GE, Scheide T, Baveja S, et al
    Pre-transplant emotional support is associated with longer survival after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2016 Jul 18. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  205. ZAMPAOLO AS, Kanold J, Tournilhac O, Franck F, et al
    Aggressive skin cancers in patients who experienced chronic GvHD after allogeneic bone marrow transplantation.
    Bone Marrow Transplant. 2016 Jul 18. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  206. GUTMAN JA, Ross K, Smith C, Myint H, et al
    Chronic graft versus host disease burden and late transplant complications are lower following adult double cord blood versus matched unrelated donor peripheral blood transplantation.
    Bone Marrow Transplant. 2016 Jul 11. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  207. SAKAGUCHI H, Matsumoto K, Yoshida N, Narita K, et al
    Dexamethasone palmitate for patients with engraftment syndrome is associated with favorable outcome for children with hematological malignancy.
    Bone Marrow Transplant. 2016 Jul 4. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  208. VAN VEEN KE, Brouwer MC, van der Ende A, van de Beek D, et al
    Bacterial meningitis in hematopoietic stem cell transplant recipients: a population-based prospective study.
    Bone Marrow Transplant. 2016 Jul 4. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  209. ESPIGADO I, Ortega-Ortega M, Montero-Granados R, Rodriguez-Torres N, et al
    Differences in stem cell transplantation activity among regions in Spain: an economic explanation.
    Bone Marrow Transplant. 2016 Jul 4. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  210. GALE RP
    Thirty years of Bone Marrow Transplantation.
    Bone Marrow Transplant. 2016 Jul 4. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  211. MUCHTAR E, Dingli D, Kumar S, Buadi FK, et al
    Autologous stem cell transplant for multiple myeloma patients 70 years or older.
    Bone Marrow Transplant. 2016 Jul 4. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  212. DEURING G, Kiss A, Halter JP, Passweg JR, et al
    Cardiac autonomic functioning is impaired among allogeneic hematopoietic stem cell transplantation survivors: a controlled study.
    Bone Marrow Transplant. 2016 Jul 4. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  213. INAGAKI J, Kurauchi K, Fukano R, Noguchi M, et al
    Heterogeneous response to recombinant thrombomodulin by grade of sinusoidal obstructive syndrome after pediatric stem cell transplantation.
    Bone Marrow Transplant. 2016 Jul 4. doi: 10.1038/bmt.2016.
    PubMed     Text format    


    June 2016
  214. ZAMA D, Biagi E, Masetti R, Gasperini P, et al
    Gut microbiota and hematopoietic stem cell transplantation: where do we stand?
    Bone Marrow Transplant. 2016 Jun 27. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  215. SHIN SH, Jeon YW, Yoon JH, Yahng SA, et al
    Comparable outcomes between younger (40 years) and older (>40 years) adult patients with severe aplastic anemia after HLA-matched sibling stem cell transplantation using fludarabine-based conditioning.
    Bone Marrow Transplant. 2016 Jun 27. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  216. HUANG WR, Li HH, Gao CJ, Bo J, et al
    Haploidentical, unmanipulated G-CSF-primed peripheral blood stem cell transplantation for high-risk hematologic malignancies: an update.
    Bone Marrow Transplant. 2016 Jun 20. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  217. LONG H, Lu ZG, Song CY, Huang YX, et al
    Long-term outcomes of HLA-haploidentical stem cell transplantation based on an FBCA conditioning regimen compared with those of HLA-identical sibling stem cell transplantation for haematologic malignancies.
    Bone Marrow Transplant. 2016 Jun 20. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  218. MAJZNER R, Sandoval C, Dozor AJ, Jin Z, et al
    Pulmonary function after hematopoietic stem cell transplantation is significantly better in pediatric recipients following reduced toxicity compared with myeloablative conditioning.
    Bone Marrow Transplant. 2016 Jun 20. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  219. ELSAID MY, Capitini CM, Diamond CA, Porte M, et al
    Successful matched unrelated donor stem cell transplant in Hemoglobin Bart's disease.
    Bone Marrow Transplant. 2016 Jun 13. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  220. TSIRIGOTIS P, Byrne M, Schmid C, Baron F, et al
    Relapse of AML after hematopoietic stem cell transplantation: methods of monitoring and preventive strategies. A review from the ALWP of the EBMT.
    Bone Marrow Transplant. 2016 Jun 13. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  221. LINK CS, Mies F, Scheele J, Kramer M, et al
    Long-term follow-up of patients with relapsed or refractory non-Hodgkin's lymphoma receiving allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2016 Jun 13. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  222. POHLEN M, Groth C, Sauer T, Gorlich D, et al
    Outcome of allogeneic stem cell transplantation for AML and myelodysplastic syndrome in elderly patients (60 years).
    Bone Marrow Transplant. 2016 Jun 13. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  223. HORN B, O'Kane S, Wattier RL, Wahlstrom JT, et al
    Risk of serious bloodstream infections is low in pediatric hematopoietic stem cell transplant (HSCT) recipients with fevers due to antithymocyte globulins and alemtuzumab.
    Bone Marrow Transplant. 2016 Jun 6. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  224. DUFORT G, Castillo L, Pisano S, Castiglioni M, et al
    Haploidentical hematopoietic stem cell transplantation in children with high-risk hematologic malignancies: outcomes with two different strategies for GvHD prevention. Ex vivo T-cell depletion and post-transplant cyclophosphamide: 10 years of experien
    Bone Marrow Transplant. 2016 Jun 6. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  225. ROTENSTEIN L, Nathan A, Ghobrial I, Antin J, et al
    Management of refractory autoimmune hemolytic anemia via allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2016 Jun 6. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  226. AHMED SS, Wang XN, Norden J, Pearce K, et al
    Identification and validation of biomarkers associated with acute and chronic graft versus host disease.
    Bone Marrow Transplant. 2016;51:890.
    PubMed     Text format    


  227. OLIVEIRA MC, Labopin M, Henes J, Moore J, et al
    Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients?
    Bone Marrow Transplant. 2016;51:889.
    PubMed     Text format    


    May 2016
  228. LEE SE, Yahng SA, Cho BS, Eom KS, et al
    Impact of pretransplant red cell transfusion on outcome after allogeneic stem cell transplantation in adult patients with severe aplastic anemia.
    Bone Marrow Transplant. 2016 May 23. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  229. GIFFORD G, Gilroy N, Dyer G, Brice L, et al
    The experience of survival following allogeneic haematopoietic stem cell transplantation in New South Wales, Australia.
    Bone Marrow Transplant. 2016 May 23. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  230. KRUGER P, Cooney J, Nivison-Smith I, Dodds A, et al
    All is not lost in accelerated phase/blast crisis and after tyrosine kinase inhibitors fail in chronic myeloid leukaemia: a retrospective study of allogeneic stem cell transplant outcomes in Australia and New Zealand.
    Bone Marrow Transplant. 2016 May 23. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  231. PETRUSKEVICIUS I, Ludvigsen M, Hjortebjerg R, Sorensen BS, et al
    Clinical relevance of galectin-1 in hematologic malignancies treated with non-myeloablative hemopoietic stem cell transplantation.
    Bone Marrow Transplant. 2016 May 23. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  232. CHRISTOPEIT M, Badbaran A, Zabelina T, Zeck G, et al
    Similar outcome of calreticulin type I and calreticulin type II mutations following RIC allogeneic haematopoietic stem cell transplantation for myelofibrosis.
    Bone Marrow Transplant. 2016 May 23. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  233. JENQ RR, van den Brink MR
    Antibiotic prophylaxis in allogeneic stem cell transplantation-what is the correct choice?
    Bone Marrow Transplant. 2016 May 23. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  234. CURI DA, Duerst RE, Badke C, Bell J, et al
    IV pentamidine for Pneumocystis jiroveci pneumonia prophylaxis in pediatric allogeneic stem cell transplant patients.
    Bone Marrow Transplant. 2016 May 23. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  235. KOTHARI J, Foley M, Peggs KS, Mackenzie S, et al
    A retrospective comparison of toxicity and initial efficacy of two autologous stem cell transplant conditioning regimens for relapsed lymphoma: LEAM and BEAM.
    Bone Marrow Transplant. 2016 May 23. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  236. AKI SZ, Inamoto Y, Carpenter PA, Storer BE, et al
    Confounding factors affecting the National Institutes of Health (NIH) chronic Graft-Versus-Host Disease Organ-Specific Score and global severity.
    Bone Marrow Transplant. 2016 May 23. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  237. GORGENS A, Murke F, Kordelas L, Giebel B, et al
    Lost in Transplantation? Unexpected shift from multipotent to late lymphomyeloid hematopoietic stem and progenitor cells in patients 1 year after hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2016 May 23. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  238. GREEN DJ, Bensinger WI, Holmberg LA, Gooley T, et al
    Bendamustine, etoposide and dexamethasone to mobilize peripheral blood hematopoietic stem cells for autologous transplantation in patients with multiple myeloma.
    Bone Marrow Transplant. 2016 May 23. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  239. TSIRIGOTIS P, Danylesko I, Gkirkas K, Shem-Tov N, et al
    Brentuximab vedotin in combination with or without donor lymphocyte infusion for patients with Hodgkin lymphoma after allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2016 May 16. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  240. LAM W, Viswabandya A, Hussain S, Messner HA, et al
    A unique case of tuberculosis dissemination presenting as cutaneous lesions in a post allogeneic stem cell transplant patient.
    Bone Marrow Transplant. 2016 May 16. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  241. LEE SY, Meehan RS, Seldin DC, Sloan JM, et al
    Effect of severe hypoalbuminemia on toxicity of high-dose melphalan and autologous stem cell transplantation in patients with AL amyloidosis.
    Bone Marrow Transplant. 2016 May 16. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  242. EL-BIETAR J, Nelson A, Wallace G, Dandoy C, et al
    RSV infection without ribavirin treatment in pediatric hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2016 May 16. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  243. OLIVER N, Luong T, Tchakarov A, Abdelrahim M, et al
    Disseminated cryptococcal infection in allogeneic stem cell transplant patients: a rare cause of acute kidney injury.
    Bone Marrow Transplant. 2016 May 9. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  244. BEIER R, Sykora KW, Woessmann W, Maecker-Kolhoff B, et al
    Allogeneic-matched sibling stem cell transplantation in a 13-year-old boy with ataxia telangiectasia and EBV-positive non-Hodgkin lymphoma.
    Bone Marrow Transplant. 2016 May 9. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  245. DESAI AV, Heneghan MB, Li Y, Bunin NJ, et al
    Toxicities of busulfan/melphalan versus carboplatin/etoposide/melphalan for high-dose chemotherapy with stem cell rescue for high-risk neuroblastoma.
    Bone Marrow Transplant. 2016 May 9. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  246. RASHIDI A, DiPersio JF, Westervelt P, Abboud CN, et al
    HLA disparity is not inconsequential in peripheral blood T-replete haploidentical hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2016 May 9. doi: 10.1038/bmt.2016.
    PubMed     Text format    


    January 2016
  247. CAIRO MS, Tarek N, Lee DA, Delaney C, et al
    Cellular engineering and therapy in combination with cord blood allografting in pediatric recipients.
    Bone Marrow Transplant. 2016;51:27-33.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Stem Cell Research is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: